| 1 | 1425381-60-7 | ASN-002 | ASN-002 | C24H28N8O2
| 抑制剂;原料药 | |
| 2 | 86772-44-3 | 4-[丁基[4-[[4,5-二氰基-1-(氰基甲基)-1H-咪唑-2-基]偶氮]-3-甲基戊基]氨基]丁酸乙酯 | ethyl 4-[butyl[4-[[4,5-dicyano-1-(cyanomethyl)-1H-imidazol-2-yl]azo]-m-tolyl]amino]butyrate | C24H28N8O2
| | |
| 3 | 1282512-48-4 | Taselisib (GDC-0032; RG-7604) | 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9 | C24H28N8O2
| 小分子抑制剂;细胞生物学试剂;小分子抑制剂，天然产物 | |
| 4 | 959754-85-9 | 4-(8-((4-(4-(tert-butyl)piperazin-1-yl)phenyl)aMino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl)furan-2-carboxaMide | 4-(8-((4-(4-(tert-butyl)piperazin-1-yl)phenyl)aMino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl)furan-2-carboxaMide | C24H28N8O2
| | |